
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $428.9M | $553.5M | $616.6M | $576.4M | $647.7M | |
Revenue Growth (YoY) | 5.85% | 29.07% | 11.4% | -6.52% | 12.36% | |
Cost of Revenues | $85.5M | $115M | $127.9M | $135.4M | $148.5M | |
Gross Profit | $343.4M | $438.5M | $488.7M | $441.1M | $499.2M | |
Gross Profit Margin | 80.07% | 79.23% | 79.26% | 76.52% | 77.08% | |
R&D Expenses | $83.9M | $99.7M | $117.1M | $130.5M | $157.2M | |
Selling, General & Admin | $61.3M | $80.4M | $77.9M | $67.4M | $74.3M | |
Other Inc / (Exp) | $864K | $98K | -$6.7M | -$184K | -$7.4M | |
Operating Expenses | $185.9M | $210.9M | $221.6M | $223.9M | $260.4M | |
Operating Income | $157.5M | $227.6M | $267.1M | $217.2M | $238.8M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $163.5M | $228.2M | $268.2M | $245.2M | $272.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $30.2M | $44M | $58.2M | $42.2M | $50M | |
Net Income to Company | $133.4M | $184.2M | $210.1M | $203M | $222.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $133.4M | $184.2M | $210.1M | $203M | $222.1M | |
Basic EPS (Cont. Ops) | $2.80 | $3.87 | $4.41 | $4.25 | $4.66 | |
Diluted EPS (Cont. Ops) | $2.80 | $3.87 | $4.40 | $4.24 | $4.65 | |
Weighted Average Basic Share | $47.2M | $47.3M | $47.4M | $47.6M | $47.5M | |
Weighted Average Diluted Share | $47.2M | $47.4M | $47.5M | $47.6M | $47.7M | |
EBITDA | $194.7M | $269.6M | $309.4M | $260.6M | $282.9M | |
EBIT | $157.5M | $227.6M | $267.1M | $217.2M | $238.8M | |
Revenue (Reported) | $428.9M | $553.5M | $616.6M | $576.4M | $647.7M | |
Operating Income (Reported) | $157.5M | $227.6M | $267.1M | $217.2M | $238.8M | |
Operating Income (Adjusted) | $157.5M | $227.6M | $267.1M | $217.2M | $238.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $134M | $150.5M | $130.5M | $165.3M | $166.3M | |
Revenue Growth (YoY) | 19.35% | 12.29% | -13.29% | 26.67% | 0.62% | |
Cost of Revenues | $23.3M | $33.2M | $33M | $37M | $38.1M | |
Gross Profit | $110.7M | $117.3M | $97.5M | $128.3M | $128.1M | |
Gross Profit Margin | 82.61% | 77.96% | 74.73% | 77.63% | 77.07% | |
R&D Expenses | $23.3M | $26.5M | $31.4M | $38M | $34.9M | |
Selling, General & Admin | $16.4M | $21.1M | $15.4M | $19.3M | $17M | |
Other Inc / (Exp) | $59K | -$34K | -$703K | -$1.9M | $378K | |
Operating Expenses | $47.1M | $55.1M | $52.1M | $65.4M | $58.5M | |
Operating Income | $63.6M | $62.3M | $45.4M | $62.9M | $69.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $63.8M | $62.5M | $51.6M | $70.5M | $80.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12.1M | $12.5M | $11.8M | $13.6M | $15.7M | |
Net Income to Company | $51.7M | $50M | $39.8M | $56.9M | $64.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $51.7M | $50M | $39.8M | $56.9M | $64.4M | |
Basic EPS (Cont. Ops) | $1.09 | $1.05 | $0.83 | $1.19 | $1.35 | |
Diluted EPS (Cont. Ops) | $1.08 | $1.05 | $0.83 | $1.19 | $1.35 | |
Weighted Average Basic Share | $47.3M | $47.4M | $47.5M | $47.6M | $47.6M | |
Weighted Average Diluted Share | $47.3M | $47.4M | $47.6M | $47.6M | $47.7M | |
EBITDA | $73.3M | $73.4M | $54.8M | $74M | $80.8M | |
EBIT | $63.6M | $62.3M | $45.4M | $62.9M | $69.7M | |
Revenue (Reported) | $134M | $150.5M | $130.5M | $165.3M | $166.3M | |
Operating Income (Reported) | $63.6M | $62.3M | $45.4M | $62.9M | $69.7M | |
Operating Income (Adjusted) | $63.6M | $62.3M | $45.4M | $62.9M | $69.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $450.6M | $570M | $596.6M | $611.2M | $648.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $86.3M | $124.9M | $127.7M | $139.4M | $149.6M | |
Gross Profit | $364.3M | $445.1M | $468.9M | $471.8M | $499.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $87.7M | $102.9M | $121.9M | $137M | $154.1M | |
Selling, General & Admin | $62.3M | $85M | $72.2M | $71.2M | $72M | |
Other Inc / (Exp) | $721K | $5K | -$7.4M | -$1.4M | -$5M | |
Operating Expenses | $187.7M | $218.8M | $218.7M | $237.2M | $253.5M | |
Operating Income | $176.6M | $226.3M | $250.2M | $234.7M | $245.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $180.4M | $227M | $257.4M | $264M | $281.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $33.5M | $44.5M | $57.4M | $44M | $52.1M | |
Net Income to Company | $146.9M | $182.5M | $199.9M | $220M | $229.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $146.9M | $182.5M | $199.9M | $220M | $229.7M | |
Basic EPS (Cont. Ops) | $3.09 | $3.83 | $4.19 | $4.61 | $4.82 | |
Diluted EPS (Cont. Ops) | $3.08 | $3.83 | $4.18 | $4.60 | $4.81 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $214.4M | $269.7M | $290.8M | $279.9M | $289.7M | |
EBIT | $176.6M | $226.3M | $250.2M | $234.7M | $245.6M | |
Revenue (Reported) | $450.6M | $570M | $596.6M | $611.2M | $648.7M | |
Operating Income (Reported) | $176.6M | $226.3M | $250.2M | $234.7M | $245.6M | |
Operating Income (Adjusted) | $176.6M | $226.3M | $250.2M | $234.7M | $245.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $134M | $150.5M | $130.5M | $165.3M | $166.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $23.3M | $33.2M | $33M | $37M | $38.1M | |
Gross Profit | $110.7M | $117.3M | $97.5M | $128.3M | $128.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $23.3M | $26.5M | $31.4M | $38M | $34.9M | |
Selling, General & Admin | $16.4M | $21.1M | $15.4M | $19.3M | $17M | |
Other Inc / (Exp) | $59K | -$34K | -$703K | -$1.9M | $378K | |
Operating Expenses | $47.1M | $55.1M | $52.1M | $65.4M | $58.5M | |
Operating Income | $63.6M | $62.3M | $45.4M | $62.9M | $69.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $63.8M | $62.5M | $51.6M | $70.5M | $80.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12.1M | $12.5M | $11.8M | $13.6M | $15.7M | |
Net Income to Company | $51.7M | $50M | $39.8M | $56.9M | $64.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $51.7M | $50M | $39.8M | $56.9M | $64.4M | |
Basic EPS (Cont. Ops) | $1.09 | $1.05 | $0.83 | $1.19 | $1.35 | |
Diluted EPS (Cont. Ops) | $1.08 | $1.05 | $0.83 | $1.19 | $1.35 | |
Weighted Average Basic Share | $47.3M | $47.4M | $47.5M | $47.6M | $47.6M | |
Weighted Average Diluted Share | $47.3M | $47.4M | $47.6M | $47.6M | $47.7M | |
EBITDA | $73.3M | $73.4M | $54.8M | $74M | $80.8M | |
EBIT | $63.6M | $62.3M | $45.4M | $62.9M | $69.7M | |
Revenue (Reported) | $134M | $150.5M | $130.5M | $165.3M | $166.3M | |
Operating Income (Reported) | $63.6M | $62.3M | $45.4M | $62.9M | $69.7M | |
Operating Income (Adjusted) | $63.6M | $62.3M | $45.4M | $62.9M | $69.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $630M | $312M | $93.4M | $92M | $99M | |
Short Term Investments | $100M | $351.2M | $484.3M | $422.1M | $393.7M | |
Accounts Receivable, Net | $82.3M | $107.6M | $92.7M | $139.9M | $113.6M | |
Inventory | $91.6M | $134.2M | $183.2M | $175.8M | $182.9M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $20.7M | $20.9M | $45.8M | $87.4M | $110.6M | |
Total Current Assets | $924.6M | $925.9M | $899.5M | $917.1M | $899.8M | |
Property Plant And Equipment | $110.9M | $159.4M | $174.9M | $200.1M | $215.1M | |
Long-Term Investments | $5M | $168.1M | $259.9M | $299.5M | $457.6M | |
Goodwill | $15.5M | $15.5M | $15.5M | $15.5M | $15.5M | |
Other Intangibles | $80.9M | $59.4M | $46.6M | $97.2M | $79M | |
Other Long-Term Assets | $4.4M | $1.8M | $2.7M | $1.9M | $2.6M | |
Total Assets | $1.3B | $1.5B | $1.5B | $1.7B | $1.8B | |
Accounts Payable | $13.8M | $15M | $9.5M | $10.9M | $36.6M | |
Accrued Expenses | $19.3M | $17.8M | $19.3M | $22.6M | $17.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $4.5M | $6.6M | $29.6M | $8.1M | $9.7M | |
Total Current Liabilities | $165M | $187.9M | $135.7M | $118.8M | $125.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $356.5M | $367M | $257.5M | $221.7M | $215.8M | |
Common Stock | $492K | $493K | $493K | $489K | $490K | |
Other Common Equity Adj | -$36M | -$18.2M | -$18.5M | -$1.1M | -$1.1M | |
Common Equity | $912.7M | $1.1B | $1.3B | $1.4B | $1.6B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $912.7M | $1.1B | $1.3B | $1.4B | $1.6B | |
Total Liabilities and Equity | $1.3B | $1.5B | $1.5B | $1.7B | $1.8B | |
Cash and Short Terms | $730M | $663.2M | $577.8M | $514.1M | $492.7M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $726.3M | $357.4M | $158.3M | $74M | $157.5M | |
Short Term Investments | $720K | $325.1M | $487.8M | $465.3M | $413.8M | |
Accounts Receivable, Net | $91.3M | $104.9M | $92.7M | $119.6M | $139.6M | |
Inventory | $101.4M | $143.2M | $174.2M | $172.9M | $197.4M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $39.6M | $29.1M | $37.2M | $89.5M | $110.2M | |
Total Current Assets | $959.3M | $959.8M | $950.2M | $921.3M | $1B | |
Property Plant And Equipment | $107.8M | $161.5M | $175.8M | $199.9M | $216.1M | |
Long-Term Investments | $8.5M | $164.1M | $213.4M | $312.9M | $369M | |
Goodwill | $15.5M | $15.5M | $15.5M | $15.5M | $15.5M | |
Other Intangibles | $75.7M | $53.9M | $43.8M | $92.7M | $74.5M | |
Other Long-Term Assets | $106.7M | $3.3M | $2.5M | $1.6M | $2.3M | |
Total Assets | $1.3B | $1.5B | $1.5B | $1.7B | $1.9B | |
Accounts Payable | $14.7M | $27.1M | $9.7M | $12.8M | $28.3M | |
Accrued Expenses | $19.2M | $14M | $12.8M | $27.9M | $21M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $3.9M | $12.5M | $42.5M | $20.9M | $26.9M | |
Total Current Liabilities | $166.3M | $178.3M | $115M | $95M | $113.1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $358M | $355.9M | $236.2M | $198.8M | $205.2M | |
Common Stock | $493K | $493K | $489K | $490K | $491K | |
Other Common Equity Adj | -$35M | -$21.9M | -$15.5M | -$3.8M | $294K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $952.5M | $1.1B | $1.3B | $1.5B | $1.7B | |
Total Liabilities and Equity | $1.3B | $1.5B | $1.5B | $1.7B | $1.9B | |
Cash and Short Terms | $727M | $682.5M | $646.1M | $539.3M | $571.3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $133.4M | $184.2M | $210.1M | $203M | $222.1M | |
Depreciation & Amoritzation | $37.2M | $42M | $42.3M | $43.4M | $44.1M | |
Stock-Based Compensation | $28.3M | $36.3M | $29.9M | $24.1M | $30M | |
Change in Accounts Receivable | -$21.8M | -$25.4M | $15M | -$47.2M | $26.2M | |
Change in Inventories | -$28.8M | -$42.6M | -$49.1M | $7.4M | -$7.1M | |
Cash From Operations | $148.8M | $191.1M | $126.8M | $154.8M | $253.7M | |
Capital Expenditures | $28.1M | $43.6M | $47.2M | $126.4M | $42.6M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $391.3M | -$457.8M | -$280.7M | -$83.3M | -$164.4M | |
Dividends Paid (Ex Special Dividend) | -$28.4M | -$37.9M | -$57M | -$66.7M | -$76.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$14.4M | -$14.9M | -$9.2M | -$8.2M | -$8.4M | |
Cash From Financing | -$41.7M | -$51.4M | -$64.6M | -$72.9M | -$82.3M | |
Beginning Cash (CF) | $131.6M | $630M | $312M | $93.4M | $92M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $498.4M | -$318M | -$218.6M | -$1.4M | $7M | |
Ending Cash (CF) | $630M | $312M | $93.4M | $92M | $99M | |
Levered Free Cash Flow | $120.7M | $147.6M | $79.6M | $28.4M | $211.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $51.7M | $50M | $39.8M | $56.9M | $64.4M | |
Depreciation & Amoritzation | $9.8M | $11.1M | $9.4M | $11.2M | $11.1M | |
Stock-Based Compensation | $5.5M | $6.5M | $4.4M | $9.2M | $7.1M | |
Change in Accounts Receivable | -$9.1M | $2.7M | -$13K | $20.3M | -$25.9M | |
Change in Inventories | -$10.5M | -$9.1M | $9M | $2.9M | -$14.5M | |
Cash From Operations | $29.5M | $52.6M | $47.6M | $72.2M | $30.6M | |
Capital Expenditures | $10.2M | $10.8M | $9.1M | $7.2M | $13.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $85.5M | $14.6M | $40.7M | -$64.2M | $58.2M | |
Dividends Paid (Ex Special Dividend) | -$9.5M | -$14.2M | -$16.8M | -$19.5M | -$21.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$9.6M | -$7.9M | -$7.2M | -$7.1M | -$9.4M | |
Cash From Financing | -$18.8M | -$21.7M | -$23.4M | -$25.9M | -$30.2M | |
Beginning Cash (CF) | $630M | $312M | $93.4M | $92M | $99M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $96.3M | $45.4M | $64.9M | -$18M | $58.5M | |
Ending Cash (CF) | $726.3M | $357.4M | $158.3M | $74M | $157.5M | |
Levered Free Cash Flow | $19.3M | $41.8M | $38.5M | $65M | $17.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $146.9M | $182.5M | $199.9M | $220M | $229.7M | |
Depreciation & Amoritzation | $37.8M | $43.3M | $40.5M | $45.2M | $44.1M | |
Stock-Based Compensation | $27.8M | $37.3M | $27.8M | $28.9M | $27.9M | |
Change in Accounts Receivable | -$8.7M | -$13.6M | $12.3M | -$26.9M | -$20M | |
Change in Inventories | -$28.5M | -$41.2M | -$31M | $1.3M | -$24.5M | |
Cash From Operations | $172.5M | $214.2M | $121.8M | $179.3M | $212.1M | |
Capital Expenditures | $33.5M | $44.1M | $45.6M | $124.4M | $48.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $379.8M | -$528.7M | -$254.6M | -$188.2M | -$42.1M | |
Dividends Paid (Ex Special Dividend) | -$30.8M | -$42.7M | -$59.5M | -$69.5M | -$78.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$19.2M | -$13.2M | -$8.5M | -$8.1M | -$10.7M | |
Cash From Financing | -$48.8M | -$54.3M | -$66.3M | -$75.4M | -$86.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $503.5M | -$368.9M | -$199.1M | -$84.3M | $83.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $139M | $170.1M | $76.2M | $54.9M | $163.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $51.7M | $50M | $39.8M | $56.9M | $64.4M | |
Depreciation & Amoritzation | $9.8M | $11.1M | $9.4M | $11.2M | $11.1M | |
Stock-Based Compensation | $5.5M | $6.5M | $4.4M | $9.2M | $7.1M | |
Change in Accounts Receivable | -$9.1M | $2.7M | -$13K | $20.3M | -$25.9M | |
Change in Inventories | -$10.5M | -$9.1M | $9M | $2.9M | -$14.5M | |
Cash From Operations | $29.5M | $52.6M | $47.6M | $72.2M | $30.6M | |
Capital Expenditures | $10.2M | $10.8M | $9.1M | $7.2M | $13.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $85.5M | $14.6M | $40.7M | -$64.2M | $58.2M | |
Dividends Paid (Ex Special Dividend) | -$9.5M | -$14.2M | -$16.8M | -$19.5M | -$21.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$9.6M | -$7.9M | -$7.2M | -$7.1M | -$9.4M | |
Cash From Financing | -$18.8M | -$21.7M | -$23.4M | -$25.9M | -$30.2M | |
Beginning Cash (CF) | $630M | $312M | $93.4M | $92M | $99M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $96.3M | $45.4M | $64.9M | -$18M | $58.5M | |
Ending Cash (CF) | $726.3M | $357.4M | $158.3M | $74M | $157.5M | |
Levered Free Cash Flow | $19.3M | $41.8M | $38.5M | $65M | $17.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.